Technology

AddToAny

Google+ Facebook Twitter Twitter

Diagnostics range launch

Horiba Medical UK has announced a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents.

Marking a milestone in its new product development programme, the Yumizen G range extends Horiba Medical’s Haematology portfolio into the complementary field of Haemostasis – a new discipline for the company.

Horiba Medical has developed a reputation for expertise and excellence in blood cell analysis. This has been utilised to deliver the new and comprehensive range of Yumizen G systems and reagents for coagulation diagnostics.

Cleve Wright, Director of Horiba Medical UK, said: “By leveraging our extensive expertise in the Haematology field, we have significantly broadened our scope in blood disease analysis into a complementary discipline.”

horiba.com/uk/medical

Related Articles

New leukaemia treatment for children

The NHS will be able to offer children a new cancer therapy labelled the “most exciting treatment advance for decades”.

My lab: red cell immunohaematology

Kate Griffiths gives a guided tour of her lab at the headquarters of the Welsh Blood Service.

My lab: morecambe bay blood sciences

Biomedical Scientist Danny Gaskin gives a guided tour of his blood sciences lab at Furness General Hospital.

Journal-based learning: iStock

Journal-based learning exercises

 

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question.

The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. 

Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl


Download PDF

Top